Showing results (21-30 of 125) with videos related to
Sort By:
Pageof 13
Annals of Internal Medicine|February 1, 1993
What is the benefit of increasing the sulfonylurea dose?S Stenman, A Melander, P H Groop, et al.Diabetes, Obesity & Metabolism|July 8, 2011
Safety and efficacy of vildagliptin versus placebo in patients with type 2 diabetes and moderate or severe renal impairment: a prospective 24-week randomized placebo-controlled trialV Lukashevich, A Schweizer, Q Shao, et al.Journal of Internal Medicine|July 1, 2009
Telomere length and progression of diabetic nephropathy in patients with type 1 diabetesF Fyhrquist, A Tiitu, O Saijonmaa, et al.Scandinavian Journal of Clinical and Laboratory Investigation|September 1, 1987
The effect of dexamethasone on the enteroinsular axisP H Groop, L C Groop, K J Tötterman, et al.Kidney International|September 28, 2006
Renal and vascular function in women with previous preeclampsia: a comparison of low- and high-degree proteinuriaK H Lampinen, M Rönnback, P-H Groop, et al.BMJ (Clinical Research Ed.)|October 31, 1992
Predictive value of microalbuminuria in patients with insulin-dependent diabetes of long durationC M Forsblom, P H Groop, A Ekstrand, et al.Scandinavian Journal of Medicine & Science in Sports|November 2, 2006
Effect of physical activity and muscle morphology on endothelial function and arterial stiffnessM Rönnback, M Hernelahti, E Hämäläinen, et al.Diabetologia|April 6, 2011
Comorbidities and survival of patients with type 1 diabetes on renal replacement therapyJ Helve, M Haapio, P-H Groop, et al.Diabetes Care|May 1, 1994
Plasma cholesteryl ester transfer protein and its relationship to plasma lipoproteins and apolipoprotein A-I-containing lipoproteins in IDDM patients with microalbuminuria and clinical nephropathyJ Kahri, P H Groop, T Elliott, et al.Diabetes|September 1, 1993
Regulation of apolipoprotein A-I-containing lipoproteins in IDDMJ Kahri, P H Groop, G Viberti, et al.Pageof 13